Figure 2

Principal coordinate analysis of samples collected from C57BL/6NHsd mice(n = 12) before (pre), immediately after (post), and 4 weeks after (4w post) treatment with TMS PO (A), enrofloxacin PO (B), enrofloxacin IP (C), topical TAB (D), or no treatment (E), ordinated using Bray–Curtis similarity.